THE REGISTERS OF ACUTE CORONARY SYNDROMES – THEIR TYPES, CHARACTERISTICS AND SIGNIFICANCE IN CLINICAL PRACTICE

Cover Page


Cite item

Full Text

Abstract

The term registry in individual application to patients with acute coronary syndrome (ACS) is discussed in this review. The author performs a detailed analysis of literature concerning objectives and goals of registries and their significance in clinical practice. The marked differences can be found between registries and randomized clinical trials (RCT). After the example of ACS registries the author shows the influence of information received according to registries limits on the formation of recommendations on treatment of patients with ACS.


About the authors

A. D. Erlikh

Federal State Institution «Scientific Research Institute of Physical Chemical Medicine»
Federal medical-biology agency, Moscow

Author for correspondence.
Email: alexeyerlikh@yahoo.com
кандидат медицинских наук, старший научный сотрудник лаборатории клинической кардиологии ФГУ «НИИ физико-химической медицины» ФМБА России Адрес: 113345, Москва, ул. Малая Пироговская, д. 1а Тел.: +7(499) 263-29-47 Russian Federation

References

  1. Ambrose J.A., Winters S.L., Arora R.R. et al. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J. Am. Coll. Cardiol. 1985; 6: 1233-1238.
  2. Murray C.J., Lopez A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349: 1269–76.
  3. Simoons M.L. Cardiovascular disease in Europe: challenges for the medical profession. Opening address of the 2002 Congress European Society of Cardiology (editorial). Eur. Heart J. 2003; 24: 8–12.
  4. Fox K.A.A. Registries and surveys in acute coronary syndrome. Eur. Heart J. 2006; 27: 2260-2262.
  5. Samorodskaya I.V. Ostrye formy ishemicheskoj bolezni serdca: neobhodimost’ resheniya problemy sopostavimosti dannyh o rasprostranennosti i letal’nosti. Bolezni serdca i sosudov. 2010; 1: 25–28.
  6. Bokeriya L.A., Stupakov I.N., Samorodskaya I.V., Bolotova E.V. Infarkt miokarda: naskol’ko otrazhaet problemu oficial’naya statistika. Kardiovaskulyarnaya terapiya i profilaktika. 2008: 4: 4–12.
  7. Yakushin S.S., Nikulina N.N. Opyt i perspektivy razvitiya `epidemiologii ostryh koronarnyh form ishemicheskoj bolezni serdca v Rossijskoj Federacii. Kardiovaskulyarnaya terapiya i profilaktika. 2009; 8 (8): 64–71.
  8. Granger C.B., Gersh B.J. Clinical trials and registries in cardiovascular disease competitive or complementary? Eur. Heart J. 2010; 31: 520–521.
  9. Brown M.L., Gersh B.J., Holmes D.R. et al. From randomized trials to registry studies: translating data into clinical information. Nat. Clin. Pract. Cardiovasc. Med. 2008; 5 (10): 613–620.
  10. Jha P., Deboer D., Sykora K. et al. Characteristics and mortality outcomes of thrombolysis trial participants and non-participants: a population-based comparison. JACC 1996; 71: 1335–1342.
  11. Steinberg B.A., Moghbeli N., Buros J. et al. Global Outcomes of ST-elevation Myocardial Infarction: Comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction Study. Am. Heart J. 2007; 154 (1): 54–61.
  12. Gitt A.K., Bueno H., Danchin N. et al. The role of cardiac registries in evidence-based medicine. Eur. Heart J. 2010; 31: 525–529.
  13. Flynn M.R., Barrett C., Cosio F.G. et al. The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur. Heart J. 2005; 26: 308–313.
  14. Alpert J.S. Are data from clinical registries of any value? Eur. Heart J. 2000; 21: 1399–1401.
  15. Registries for evaluating patient outcomes: user’s guide. AHRQ Publication No. 07-EHC001-1. 2007.
  16. Zahn R., Schiele R., Schneider S. et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J. Am. Coll. Cardiol. 2001; 37: 1827–1835.
  17. Stenestrand U., Wallentin L. For the Swedish Register of Cardiac Intensive Care (RIKS-HIA) Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival. JAMA. 2001; 285: 430–436.
  18. Cannon C.P., Braunwald E., McCabe C.H. et al. For the Pravastatin or Atorvastatin Evaluation and Infection Therapy — Thrombolysis in Myocardial Infarction 22 Investigators. Comparison of Intensive and Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. N. Eng. J. Med. 2004; 350.
  19. Fox K.A.A., Steg F.G., Eagle K.A. et al. Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006. JAMA. 2007; 297: 1892–1900.
  20. Mehta R.H., Roe M.T., Chen A.Y. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch. Intern. Med. 2006; 166 (18):2027–2034.
  21. Fassa A.A., Urban P., Radovanovic D. et al AMIS Plus Investigators Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart. 2005; 91 (7):882–888.
  22. Yavelov I.S., Gracianskij N.A. Rossijskij registr ostryh koronarnyh sindromov: lechenie i ishody v stacionare pri ostrom koronarnom sindrome bez pod`emov segmenta ST. Kardiologiya. 2003; 12: 16-29.
  23. Swedberg K. What can we learn from Europe? Heart. 2005; 91 (2): 21–23.
  24. www.ncdr.com
  25. www.euroheartsurvey.org
  26. www.escardio.org/guidelines-surveys/eorp/Documents/eurobservational-research-programe.pdf
  27. Scholte O.P., Reimer W.J.M., Gitt A.K., Boersma E. et al. Cardiovascular Disease in Europe. Euro Heart Survey-2006. Sophia Antipolis: European Society of Cardiology. 2006. http://www.eacardio. org/guidelines-surveys/ehs/pages/ reports.aspx
  28. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (Update of 2007 Guidelines). JACC. 2011; 57: 1920–1959.
  29. http://www.outcomes-umassmed.org/GRACE/default.aspx
  30. Steg G., Goldberg R.J., Gore J.M. et al for the GRACE Investigators. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am. J. Cardiol. 2002; 90: 358–363.
  31. Gurfinkel E.P., Bozovich G.E., Dabbous O. et al. Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina. Thromb. J. 2005, 3: 22.
  32. ACC/AHA Guidelines for the Management of Patients with Unstable angina/non-ST-segment Elevation Myocardial Infarction: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines. Circulation. 2007; 116: 148–304.
  33. Goldberg R.J., Steg P.G., Sadiq I. et al. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am. J. Cardiol. 2002; 89: 791–796.
  34. Avezum A., Makdisse M., Spencer F. et al for the GRACE Investigators. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am. Heart J. 2005; 149: 67–73.
  35. Van de Werf F., Bax J., Betriu A. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart J. 2008; 29: 2909–2945.
  36. Nallamothu B.K., Fox K.A.A, Kennelly B.M. et al on behalf of the GRACE Investigators. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart. 2007; doi: 10.1136/hrt.2006.112–847.
  37. Fox K.A.A., Anderson F.A. Jr., Dabbous O.H. et al on behalf of the GRACE Investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart. 2007; 93: 177–182.
  38. The GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am. Heart J. 2001; 141: 190–199.
  39. Eagle K.A., Nallamothu B.K., Mehta R.H. et al for the Global Registry of Acute Coronary Events (GRACE) Investigators. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur. Heart J. 2008; 29: 609–617.
  40. Granger C.B., Goldberg R.J., Dabbous O. et al for the Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch. Intern. Med. 2003; 163: 2345–2353.
  41. Hoekstra J.W., Pollak C.V., Roe M.T. et al. Improving the care of patients with non-ST-elevation acute coronary syndromes in emergency department: the CRUSADE initiative. Acad. Emerg. Med. 2002; 9 (11): 1146–1155.
  42. http://www.clinicaltrialresults.org
  43. Peterson E.D., Roe M.T., Mulgund J. et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006; 295: 1912–1920.
  44. Bhatt D., Roe M.T., Peterson E.D. et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes. Results from the CRUSADE quality improvement initiative. JAMA. 2004; 292: 2096–2104.
  45. Alexander K.P., Roe M.T., Chen A.Y. et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE national quality improvement initiative. J. Am. Coll. Cardiol. 2005; 46: 1479–1487.
  46. Tricoci P., Peterson E.D., Mulgund J. et al. Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE). Am. J. Cardiol. 2006; 98: 1172–1176.
  47. Amsterdam E.A., Peterson E.D., Ou F.-S. et al. Comparative Trends in Guidelines Adherence Among Patients With Non-STSegment Elevation Acute Coronary Syndromes Treated With Invasive Versus Conservative Management Strategies Results From the CRUSADE Quality Improvement Initiative Am. Heart J. 2009; 158 (5): 748–754.
  48. Alexander K.P., Chen A.Y., Roe M.T. et al. Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non-STSegment Elevation Acute Coronary Syndromes. JAMA. 2005; 294: 3108–3116.
  49. Yang X., Alexander K.P., Chen A.Y. et al. The Implications of Blood Transfusions for Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Results From the CRUSADE National Quality Improvement Initiative. Am. Coll. Cardiol. 2005; 46: 1490–1495.
  50. Subherwal S., Bach R.G., Chen A.Y. et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation. 2009; 119 (14): 1873–1882.
  51. Gibson C.M. NRMI and current treatment patterns for ST-elevation myocardial infarction Am. Heart J. 2004; 148 (5): 29–33.
  52. Roger W.J., Canto J.G., Lambrew C.T. et al. Temporal trends in the treatment over 1.5 million patient with myocardial infarction in the U.S. from 1990 through 1999. The National Registry of Myocardial Infarction 1,2 and 3. JACC. 2000; 36 (7): 2056–2063.
  53. Cannon C.P., Gibson C.M., Lambrew C.T. et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000; 283: 2941–2947.
  54. Pinto D.S., Kirtane A.J., Nallamothu B.K. et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction. Implica tions When Selecting a Reperfusion Strategy. Circulation. 2006; 114: 2019–2025.
  55. Cannon C.P., Gibson C.M., Lambrew C.T. et al. for the NRMI 2 and 3 Investigators. Longer thrombolysis door-to-needle times are associated with increased mortality in acute myocardial infarction: an analysis of 85,589 patients in the National Registry of Myocardial Infarction 2+3. J Am Coll Cardiol. 2000; 35 (A): 376A. Abstract
  56. Rogers W.J., Bowlby L.J., Chandra N.C. et al. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994; 90: 2103–2114.
  57. Nallamothu B.K., Bates E.R., Herrin J. et al for the NRMI Investigators. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005; 111: 761–767.
  58. www.ncdr.com/WebNCDR/Action/Default.aspx
  59. Peterson E.D., Roe M.T., Chen A.Y. et al. The NCDR ACTION Registry - GWTG: transforming contemporary acute myocardial infarction clinical care. Heart. 2010; 96: 1798–1802.
  60. Roe M.T., Chen A.Y., Cannon C.P. et al. CRUSADE and ACTION-GWTG Registry Participants. Temporal changes in the use of drug-eluting stents for patients with non-ST-Segmentelevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress Adverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries. Circ. Cardiovasc. Qual. Outcomes. 2009; 2 (5): 414–420.
  61. Kadakia M.B., Desai N.R., Alexander K.P. et al. National Cardiovascular Data Registry Use of Anticoagulant Agents and Risk of Bleeding Among Patients Admitted With Myocardial Infarction.A Report From the NCDR ACTION Registry — GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry — Get With the Guidelines). Am. Coll. Cardiol. Intv. 2010; 3: 1166–1177.
  62. Parikh S.V., de Lemos J.A., Jessen M.E. et al. CRUSADE and ACTION Registry-GWTG Participants. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network RegistryGet With The Guidelines). JACC Cardiovasc Interv. 2010; 3 (4): 419–427.
  63. Diercks D.D., Kontos M.C., Chen A.Y. et al. Utilization and Impact of Pre-Hospital Electrocardiograms for Patients With Acute ST-Segment Elevation Myocardial Infarction. Data From the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. J. Am. Coll. Cardiol. 2009; 53: 161–166.
  64. Kim M.S., Wang T.Y., Ou F.S. et al. Association of Prior Coronary Artery Bypass Graft Surgery With Quality of Care of Patients With Non-ST-Segment Elevation Myocardial Infarction: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines. Am. Heart J. 2010; 160: 951–957.
  65. www.euroheartsurvey.org
  66. http://www.escardio.org/guidelines-surveys/ehs/Pages/surveyslist.aspx
  67. Hasdai D., Behar S., Wallentin L. et al. A prospective survey of the characteristics, treatments and outcomes of patients with Acute Coronary Syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur. Heart J. 2002; 23: 1190–1201.
  68. Hasdai D., Porter A., Rosengren A. et al. Effect of gender on outcome of acute coronary syndromes. Am. J. Cardiol. 2003; 91: 1466–1469.
  69. Lev E.I., Battler A., Behar S. et al. Frequency, characteristics and outcome of acute coronary syndromes — The Euro Heart Survey of Acute Coronary Syndromes experience. Am. J. Cardiol. 2003; 91: 224–227.
  70. Nieuwlaat R., Lenzen M., Crijns H.J.G.M. Which factors are associated with the application of reperfusion therapy in ST-elevation acute coronary syndromes? Lessons from the Euro Heart Survey on Acute Coronary Syndromes I. Cardiology. 2006; 106: 137–146.
  71. 147 Mandelzweig L., Battler A., Boyko V. et al. for the Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment and outcome of patients with ACS in Europe and the Mediterranean basin in 2004. Eur. Heart J. 2006; 27 (19): 2285–2293.
  72. Schiele F., Hochadel M., Tubaro M. et al. EHS-ACS-III: Euro Heart Survey Acute Coronary Syndromes III. Доклад на конгрес- се EHS Congress 13.08.2010. http://www.escardio.org/congresses/ esc-2010/congress-reports/Pages/710-4-EHS-ACS-III.aspx
  73. Danchin N. Winning the battle against ST-segment-elevation myocardial infarction: continued progress, but still a long way to go. Eur. Heart J. 2010; 31 (21): 2580–2582.
  74. Danchin N., Battler A., Brikhead J. et al. Euro Heart Survey Acute Coronary Syndrome snapshot 2009: Characteristics, management and in-hospital outcome of AMI people thought EHS member countries. ECS Congress. 2010.
  75. Gottlieb S., Brikhead J., Bueno H. et al. Euro Heart Survey Acute Coronary Syndrome snapshot 2009: regional disparities in baseline characteristics and management. ECS Congress. 2010.
  76. Yan A.T., Jong Ph., Yan R.T. et al. Clinical trial — derived risk model may not generalize to real-world patients with acute coronary syndrome. Am. Heart J. 2004; 148 (6): 1020–1027.
  77. Bagnall A.J., Yan A.T., Yan R.T. et al for the Canadian Acute Coronary Syndromes Registry II Investigators. Optimal Medical Therapy for Non-ST-Segment-Elevation Acute Coronary Syndromes. Exploring Why Physicians Do Not Prescribe Evidence-Based Treatment and Why Patients Discontinue Medications After Discharge. Circulation: Cardiovascular Quality and Outcomes. 2010; 3: 530–537.
  78. Kornder J.M., DeYoung J.P., Welsh R.C. et al. Lessons from CANRACE registry: care gaps in ACS in Canada: medication adherence at hospital discharge and at six months. Canadian Cardiovascular Congress. 2010. Abstract 025.
  79. Collinson J., Flather M.D., Fox K.A. et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK Eur. Heart J. 2000; 21: 1450–1457.
  80. Bueno H., Bardaji A., Fernandez-Ortiz A. et al.Management of Non-ST-Segment-Elevation Acute Coronary Syndromes in Spain. The DESCARTES (Descripcion del Estado de los Sindromes Coronarios Agudos en un Registro Temporal ESpanol) Study. Rev. Esp. Cardiol. 2005; 58: 244–252.
  81. Zahn R., Schiele R., Schneider S. et al. Small differences in nonfatal in-hospital reinfarctions complicating acute myocardial infarction as observed in current randomised controlled trials will not essentially influence long-term mortality. Results from the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry. Z. Kardiol. 2003; 92 (10): 847–851.
  82. Zahn R., Schiele R., Schneider S. et al. Maximale Individuelle Therapie beim Akuten Myokardinfarkt (MITRA) und das MyokardInfarkt Register-M. Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). Herz. 2000; 25 (7): 667–675.
  83. Widimsky P., Zelizko M., Jansky P. et al. The incidence, treatment strategies and outcomes of acute coronary syndromes in the «reperfusion network» of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int. J. Cardiol. 2007; 119 (2): 212–219.
  84. Polonsky L., Gasior M., Gierlotka M. et al. Polish registry of acute coronary syndromes (PL-ACS). Characteristics, treatment and outcomes of patients with acute coronary syndromes in Poland. Kardiol. Pol. 2007; 65 (8): 861–872.
  85. http://www.csikerala.org/acsregistry.php
  86. Gao R., Patel A. et al. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart. 2008; 94: 554–560.
  87. Ferrieres J., Bakhai A., Iniguez A. et al. Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Curr. Med. Res. Opin. 2010; 26 (9): 2193– 2202.
  88. Bakhai A., Ferrieres J., Iniguez A. et al. International data on supportive therapies at 1 year in acute coronary syndrome patients undergoing PCI: results from the APTOR study. Eur. J. Cardiovascul. Prev. Rehabilit., 2011.
  89. Yanushkevichus Z.I., Bluzhas I.N., Staliorajtite E.N. i dr. Registr ostrogo infarkta miokarda: vozmozhnosti sovershenstvovaniya diagnostiki i vyyasneniya suschnosti vnezapnoj smerti. «Vnezapnaya smert’». Materialy II sovetsko-amerikanskogo simpoziuma. Indianapolis, SShA. 1979.
  90. Working Group on Ischemic Heart Disease Registers, 7th Copenhagen, 1971. Ischemic heart disease registers; report of the Fifth Working Group, including a second revision of the operating protocol. Copenhagen. April 26–29, 1971. Regional Office for Europe, WHO. 1971.
  91. Tunstall-Pedoe H. For the WHO MONICA Project. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): A major international collaboration. J. Clin. Epidemiol. 1988; 41: 105–114.
  92. Yavelov I.S., Gracianskij N.A. Rossijskij registr ostryh koronarnyh sindromov: lechenie i ishody v stacionare pri ostrom koronarnom sindrome s pod`emami segmentov ST. Kardiologiya. 2004; 44 (4): 4–13.
  93. Yavelov I.S. Lechenie ostrogo koronarnogo sindroma bez pod`emov segmenta ST v Rossii (po dannym registra ostryh koronarnyh sindromov 2000-2001 i 2003 gg). Serdce. 2005; 4 (4): 210–213.
  94. Aleksandrovskij A.A., Makarkin N.P., Ashirov R.Z. i dr. Nekotorye rezul’taty realizacii obscheevropejskoj programmy «Registr ostrogo koronarnogo sindroma» v respublike Mordoviya. Materialy II Nacional’nogo kongressa terapevtov. Moskva. 2007. 9 s.
  95. Duplyakov D.V., Hohlunov S.M., Tuhbatova A.A. i dr. Vozmozhnost’ gospital’nogo registra OKSPST v ocenke kachestva medicinskoj pomoschi (sravnenie s dannymi Evropejskogo registra ACS-II). Materialy III S`ezda kardiologov privolzhskogo federal’nogo okruga. Samara. 2010. 162–163 s.
  96. Duplyakov D.V., Hohlunov S.M., Tuhbatova A.A. i dr. Vozmozhnost’ gospital’nogo registra OKSBPST v ocenke kachestva medicinskoj pomoschi (sravnenie s dannymi Evropejskogo registra ACS-II). Materialy III S`ezda kardiologov privolzhskogo federal’nogo okruga. Samara. 2010. 163–164 s.
  97. Zolotar’ A.K. Registr ostryh koronarnyh sindromov u zhitelej g. Noyabr’ska (Yamalo-Neneckij avtonomnyj okrug). Materialy I Evrazijskogo kongressa kardiologov i III Nacional’nogo kongressa kardiologov Kazahstana. Astana. 2010. 119 s.
  98. Mihal’chikova N.A., Burova N.N. Pokazateli letal’nosti ot ostrogo infarkta miokarda v zavisimosti ot vozmozhnosti okazaniya stacionarom vysokotehnologichnyh metodov lecheniya (po dannym registra ostrogo infarkta miokarda v Sankt-Peterburge). Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii. 2009; 19: 46–47.
  99. Kosmacheva E.D., Filimonova K.V., Prohanov V.A., Shelestova I.A. Dannye registra ostrogo infarkta miokarda v Krasnodarskom krae. Kardiovaskulyarnaya terapiya i profilaktika. 2008, 7 (6), prilozhenie 1: 191.
  100. Bojcov S.A., Yavelov I.S., Shal’nova S.A., i soavt. Nacional’nyj registr ostrogo koronarnogo sindroma v Rossii: sovremennoe sostoyanie i perspektivy. Kardiovaskulyarnaya terapiya i profilaktika. 2007; 6 (4): 115–120.
  101. Chazov E.I., Bojcov S.A. Okazanie medicinskoj pomoschi bol’nym s ostrym koronarnym sindromom v ramkah programmy sozdaniya regional’nyh i pervichnyh sosudistyh centrov v Rossijskoj Federacii. Kardiologicheskij vestnik. 2008; III (XV), № 2: 5–11.
  102. Bojcov S.A., Krivonos O.V., Oschepkova E.V. i dr. Ocenka `effektivnosti realizacii meropriyatij, napravlennyh na snizhenie smertnosti ot sosudistyh zabolevanij v regionah, vklyuchennyh v programmu v 2008 godu, po dannym monitoringa Minzdravsocrazvitiya Rossii i Registra OKS. Menedzher zdravoohraneniya. 2010; 5: 19–29.
  103. Erlih A.D., Gracianskij N.A., ot imeni uchastnikov registra REKORD. Registr ostryh koronarnyh sindromov REKORD. Harakteristika bol’nyh i lechenie do vypiski iz stacionara. Kardiologiya. 2009; 7: 4–12.
  104. Erlih A.D., Gracianskij N.A. i uchastniki registra REKORD. Registr REKORD. Lechenie bol’nyh s ostrymi koronarnymi sindromami v stacionarah, imeyuschih i ne imeyuschih vozmozhnosti vypolneniya invazivnyh procedur. Kardiologiya. 2010; 7: 8–14.
  105. Erlih A.D., Gracianskij N.A., uchastniki registra REKORD. Ostryj koronarnyj sindrom u bol’nyh saharnym diabetom. Dannye registra REKORD. Kardiologiya. 2011; 11: 16–21.
  106. Erlih A.D., Gracianskij N.A., ot imeni uchastnikov registra REKORD. Rezul’taty shestimesyachnogo nablyudeniya za bol’nymi s ostrymi koronarnymi sindromami v Rossijskom registre REKORD. Kardiologiya. 2011; 12: 18–23.
  107. Erlih A.D. Shkala dlya rannej ocenki riska smerti i razvitiya infarkta miokarda v period prebyvaniya v stacionare bol’nyh s ostrymi koronarnymi sindromami (na osnove dannyh registra REKORD). Kardiologiya. 2010; 10: 11–16.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies